Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-21

FDA Approved: ZOLPIDEM TARTRATE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved Breckenridge Pharmaceutical, Inc.'s supplemental application for zolpidem tartrate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

SUPPL AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)